Zoetis (ZTS)

Zoetis Stock Analysis & Ratings

ZTS Stock Chart & Stats

Day’s Range$164.2 - $168.01
52-Week Range$158.27 - $249.27
Previous Close$163.08
Average Volume (3M)2.48M
Market Cap$77.81B
P/E Ratio37.9
Next EarningsAug 04, 2022
Dividend Yield1.15 (0.69%)
Smart Score5
EPS (TTM)4.36



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Zoetis’s price range in the past 12 months?
Zoetis lowest stock price was $158.27 and its highest was $249.27 in the past 12 months.
    What is Zoetis’s market cap?
    Zoetis’s market cap is $77.81B.
      What is Zoetis’s price target?
      The average price target for Zoetis is $231.40. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $254.00 ,the lowest forecast is $208.00. The average price target represents 39.96% Increase from the current price of $165.33.
        What do analysts say about Zoetis?
        Zoetis’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
          When is Zoetis’s upcoming earnings report date?
          Zoetis’s upcoming earnings report date is Aug 04, 2022 which is in 80 days.
            How were Zoetis’s earnings last quarter?
            Zoetis released its earnings results on May 05, 2022. The company reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.23 by $0.09.
              Is Zoetis overvalued?
              According to Wall Street analysts Zoetis’s price is currently Undervalued.
                Does Zoetis pay dividends?
                Zoetis pays a Quarterly dividend of $0.32 which represents an annual dividend yield of 0.69%. Zoetis’s last Quarterly dividend payment was on Jun 01, 2022. Zoetis’s upcoming ex-dividend date is Apr 20, 2022
                  What is Zoetis’s EPS estimate?
                  Zoetis’s EPS estimate for its next earnings report is not yet available.
                  How many shares outstanding does Zoetis have?
                  Zoetis has 470,630,000 shares outstanding.
                    What happened to Zoetis’s price movement after its last earnings report?
                    Zoetis reported an EPS of $1.32 in its last earnings report, beating expectations of $1.23. Following the earnings report the stock price went down -3.059%.
                      Which hedge fund is a major shareholder of Zoetis?
                      Among the largest hedge funds holding Zoetis’s share is Sands Capital Management LLC. It holds Zoetis’s shares valued at 557M.


                        Zoetis Stock Analysis

                        The Zoetis stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                        Learn more about TipRanks Smart Score

                        Company Description


                        Founded in 1952, New Jersey-based Zoetis, Inc. is the world's largest manufacturer of medicine and vaccinations for pets and livestock in the United States and internationally. Its products are complemented by diagnostic products, genetic tests, bio devices and services.

                        Similar Stocks
                        Price & Change
                        Idexx Laboratories
                        Phibro Animal Health
                        Sanofi-Aventis Sa

                        Popular Stocks

                        What's Included in PREMIUM?
                        Make informed decisions based on Top Analysts' activity
                        Know what industry insiders are buying
                        Get actionable alerts from top Wall Street Analysts
                        Find out before anyone else which stock is going to shoot up
                        Get powerful stock screeners & detailed portfolio analysis